Form D · Biotechnology
Lifeward Ltd.
Hudson, MA · CIK 0001607962
Offering snapshot reported Jul 8, 2026 · SEC filing
- Reported sold
- $11.2M Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 6, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2026 | Initial | $11,160,000 | No comparison | 5 | SEC filing |
| Apr 2, 2026 | Initial | $20,000,000 | No comparison | 2 | SEC filing |
| Jan 13, 2025 | Initial | $5,000,003 | No comparison | 4 | SEC filing |
| Oct 6, 2021 | Initial | $16,293,754 | No comparison | 9 | SEC filing |
| Feb 26, 2021 | Initial | $40,000,001 | No comparison | 22 | SEC filing |
| Dec 18, 2020 | Initial | $8,000,004 | No comparison | 7 | SEC filing |
| Jul 8, 2020 | Initial | $4,500,006 | No comparison | 11 | SEC filing |
| Jun 19, 2019 | Initial | $0 | No comparison | 5 | SEC filing |
| Jun 19, 2019 | Initial | $5,000,004 | No comparison | 2 | SEC filing |
| Jun 19, 2019 | Initial | $0 | No comparison | 5 | SEC filing |
| Apr 9, 2019 | Initial | $4,250,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-589997
Source: Form D, filed Jul 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Almog Adar | Executive |
| Ning Cong | Director |
| Arik Dan | Director |
| Jeff Dykan | Director |
| Yohanan Engelhardt | Director |
| Ori Gon | Executive |
| William Mark Grant | Director, Executive |
| Chunlin (Allen) Han | Director |
| Yasushi Ichiki | Director |
| Larry Jasinski | Director, Executive |
| Ofir Koren | Executive |
| Michael Lawless | Executive |
| Hadar Levy | Director |
| Jeannine Lynch | Executive |
| Robert J Marshall | Director |
| John William Poduska | Director |
| Charles Remsberg | Executive |
| Randel Richner | Director |
| Michael Swinford | Director |
| Joseph Turk | Director |
| Peter Wehrly | Director |
| Wayne B. Weisman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Cabot Road
Hudson, MA, 01749
Phone: 15082511154
Hudson, MA, 01749
Phone: 15082511154